A recent study has demonstrated how RNA sequencing can enhance the genetic classification of B-cell precursor acute ...
When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...
BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...
MedPage Today on MSN21h
siRNA Agent Slashes Lipoprotein(a) LevelsNovel small interfering RNA (siRNA) agent lepodisiran drastically cut levels of lipoprotein(a), or Lp(a), in the phase II ALPACA trial. The 400-mg dose cut Lp(a) by 93.9 percentage points compared ...
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...
Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...
Researchers say they are exploring therapeutic options to block fatty acid accumulation and immunosuppressive signals between ...
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...
Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...
Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...
RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback